Namocell Highlighted in Nature Publication for Efficient Single Cell Cloning of Human Pluripotent Stem Cells
![Bio-Techne Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/11/Bio_Techne__Logo-1024x256.jpg)
MINNEAPOLIS, Nov. 17, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a single-cell cloning workflow study using the Namocell™ Single Cell Dispenser in Nature Protocols: Efficient and safe single-cell cloning of human pluripotent stem cells using the chroman 1, emricasan, polyamines, and trans-ISRIB (CEPT) cocktail. This publication outlines a robust and scalable workflow for cloning human pluripotent stem cells […]
Understanding Human Pluripotent Stem Cell States and Their Applications with Thorold Theunissen
![Embryonic Stem Cells](https://nationalstemcelltherapy.com/wp-content/uploads/2022/07/embryonic-stem-cells-1024x682.jpg)
Thorold Theunissen, Ph.D., of the Washington University School of Medicine in St. Louis shares his work using naive stem cells to model trophoblast development. Video Transcript: [MUSIC] My lab studies human pluripotent stem cells. We’re especially interested in understanding different stem cell states and their applications. Recently, we’ve become really excited about using naive stem […]